SmallCap
CompaniesMapStatistics

주식회사 알바이오

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Stock Code: 003190

Company Name주식회사 알바이오
English NameR Bio CO., LTD.
Business Reg. No.1028130395
CEO최경호
Address서울특별시 금천구 가산디지털2로 98 (가산동, IT캐슬) 2동 305호
Industry그 외 기타 의료용품 및 의약 관련제품 제조업
Industry Code21100
Established19610705
Phone02-874-0686
Websitewww.rbio.co.kr
Regular Employees93persons
Corp. Reg. No.1101110006448

Investment Metrics


Market Cap
-
Op. Margin
-20.9%
ROE
-128.62%
Debt Ratio
306.68%

Certification Status


Venture Certified

Cert. History
신기술기업(고도기술수반산업)2005-12-20 ~ 2007-12-190511370321020072005-12-20
기술평가보증기업(기금)2009-04-10 ~ 2010-04-09200901031782005-12-20
혁신성장유형2023-06-07 ~ 2026-06-06202306070300172005-12-20

Financial Statements


3-Year Financial Data

Revenue CAGR +104.6%

Item202420232022
Revenue

219B

140B

52B

Operating Profit

-46B

-87B

-104B

Net Profit

-141B

-201B

-202B

Total Assets

446B

490B

880B

Total Liabilities

336B

270B

507B

Total Equity

110B

220B

373B

Risk Indicators


4 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
219B

128.0%

vs. 3-Year Avg.: 96B
Operating Profit
-46B

52.0%

vs. 3-Year Avg.: -96B
Op. Margin
-20.9%

83.9%

vs. 3-Year Avg.: -130.2%
Debt Ratio
306.7%

137.1%

vs. 3-Year Avg.: 129.4%
ROE
-128.6%

76.6%

vs. 3-Year Avg.: -72.8%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
최경호사내이사연구개발
강성근사내이사연구개발
변대중사내이사법무
이항영사내이사연구개발
이승택사외이사경영
문흥안감사감사

Employment Status


NPS Subscribers

123persons

CEO최경호
Est. Avg. Annual Salary

4,21910K

(35210K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+25persons

Left (12 mo)

-16persons

Net Change (12 mo)

+9persons

NPS Join Date

1999-09-01

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

308 Patents
171 Registered
32 in 3 Years
A61 의학/수의학/위생 (112)
C12 생화학/미생물학 (26)
A23 식품/식료품 (20)
G16 정보통신기술(ICT) (17)
C07 유기화학 (12)
Patent TitleApplicantApplication No.Filing DateStatus
아임계 이산화탄소를 이용하여 스피큘 내 리포좀을 함침시키는 방법주식회사 에스알바이오텍10202400777472024-06-14등록
이미다조피리딘 또는 이미다조피라진 화합물, 이의 제조 방법, 약학 조성물 및 용도상하이 에스아이엠알 바이오테크놀로지 컴퍼니 리미티드10202570390942024-04-24공개
대마 식혜 및 이의 제조 방법농업회사법인 (주)헴프앤알바이오|국립경국대학교 산학협력단10202400529692024-04-19공개
흑미강 생물전환산물을 유효성분으로 포함하는 암 및 암 관련 피로 개선용 조성물(주)에스티알바이오텍|주식회사 엘스케이10202400439032024-04-01공개
흑미강 생물전환산물을 유효성분으로 포함하는 호중구감소증의 예방 또는 치료용 조성물(주)에스티알바이오텍|주식회사 엘스케이10202400439042024-04-01공개

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "서울특별시 금천구",
  "ceo_name": "최경호",
  "certificate": [
    {
      "cert_number": "051137032102007",
      "changes": "",
      "disclosure_date": "2005-12-20",
      "first_cert_date": "2005-12-20",
      "no": "1",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2005-12-20 ~ 2007-12-19"
    },
    {
      "cert_number": "20090103178",
      "changes": "",
      "disclosure_date": "2009-04-10",
      "first_cert_date": "2005-12-20",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2009-04-10 ~ 2010-04-09"
    },
    {
      "cert_number": "20230607030017",
      "changes": "대표자",
      "disclosure_date": "2023-06-07",
      "first_cert_date": "2005-12-20",
      "no": "3",
      "type": "혁신성장유형",
      "valid_period": "2023-06-07 ~ 2026-06-06"
    }
  ],
  "company_name": "주식회사 알바이오",
  "financials": {
    "2022": {
      "capital_stock": 64076170000,
      "cost_of_sales": 4446145000,
      "current_assets": 15195060000,
      "current_liabilities": 32721164000,
      "gross_profit": 796031000,
      "net_income": -20200000000,
      "net_income_bs": -20200000000,
      "non_current_assets": 72793792000,
      "non_current_liabilities": 17973017000,
      "non_operating_expenses": 16802806000,
      "non_operating_income": 6990475000,
      "operating_profit": -10387669000,
      "revenue": 5242176000,
      "sga_expenses": 11183700000,
      "total_assets": 87988852000,
      "total_equity": 37294671000,
      "total_liabilities": 50694181000
    },
    "2023": {
      "capital_stock": 66596169000,
      "cost_of_sales": 9442659000,
      "current_assets": 11042593000,
      "current_liabilities": 7650656000,
      "gross_profit": 4569711000,
      "net_income": -20133300000,
      "net_income_bs": -20171946000,
      "non_current_assets": 37992201000,
      "non_current_liabilities": 19374791000,
      "non_operating_expenses": 24800934000,
      "non_operating_income": 13390429000,
      "operating_profit": -8722795000,
      "revenue": 14012370000,
      "sga_expenses": 13292506000,
      "total_assets": 49034794000,
      "total_equity": 22009347000,
      "total_liabilities": 27025447000
    },
    "2024": {
      "capital_stock": 68096170000,
      "cost_of_sales": 14455853000,
      "current_assets": 16599370000,
      "current_liabilities": 12853429000,
      "gross_profit": 7493509000,
      "net_income": -14096564000,
      "net_income_bs": -14121262000,
      "non_current_assets": 27972938000,
      "non_current_liabilities": 20758917000,
      "non_operating_expenses": 10845168000,
      "non_operating_income": 1335861000,
      "operating_profit": -4587257000,
      "revenue": 21949362000,
      "sga_expenses": 12080766000,
      "total_assets": 44572308000,
      "total_equity": 10959962000,
      "total_liabilities": 33612346000
    }
  },
  "industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
  "investment": [],
  "phone": "02-6978-****",
  "source": "pg_migration"
}

{
  "address": "서울특별시 금천구 가산디지털2로",
  "brno": "102813****",
  "cappedWarning": false,
  "companyName": "주식회사 알바이오",
  "estimatedAvgAnnualSalary": 42190356,
  "estimatedAvgMonthlySalary": 3515863,
  "fetchedAt": "2026-03-05T11:22:09.124Z",
  "industryCode": "154903",
  "industryName": "건강 보조용 액화식품 제조업",
  "joinDate": "19990901",
  "last12MonthsHired": 25,
  "last12MonthsLeft": 16,
  "last12MonthsNetChange": 9,
  "leaveDate": null,
  "monthlyPensionAmount": 41082860,
  "monthlyTrend": [
    {
      "lostSubscribers": 16,
      "newSubscribers": 25,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6635330",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 123,
  "turnoverMonths": 1
}

Data Sources


Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentDART
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
Venture System Detail2026-03-05
Collected
nps2026-03-05
Collected
DART Financial2026-02-27
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected